These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 662870)

  • 21. Resistance of germfree rats to indomethacin-induced intestinal lesions.
    Robert A; Asano T
    Prostaglandins; 1977 Aug; 14(2):333-41. PubMed ID: 331401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naloxone is protective against indomethacin-induced intestinal ulceration in the rat.
    Waisman Y; Dinari G; Marcus H; Ligumsky M; Rosenbach Y; Zahavi I; Nitzan M
    Gastroenterology; 1985 Jul; 89(1):86-91. PubMed ID: 2989073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of indomethacin-induced intestinal ulcers by various catatoxic steroids.
    Selye H
    Exp Med Surg; 1970; 28(2):169-78. PubMed ID: 4398804
    [No Abstract]   [Full Text] [Related]  

  • 24. Triple Recycling Processes Impact Systemic and Local Bioavailability of Orally Administered Flavonoids.
    Dai P; Zhu L; Luo F; Lu L; Li Q; Wang L; Wang Y; Wang X; Hu M; Liu Z
    AAPS J; 2015 May; 17(3):723-36. PubMed ID: 25762448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,6-Dimethyl-4-oxo-1,6,7,8,9,9a-hexahydro-4H-pyrido(1,2-a)- pyrimidine-3-carboxamide (Ch-127) protects against the intestinal damage in rats caused by two weeks' daily administration of indomethacin.
    Knoll J; Gyires K; Hermecz I
    Drugs Exp Clin Res; 1987; 13(5):253-8. PubMed ID: 3500028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventive effect of PGI2, 7-oxo-PGI2 and 17-aza-PGF2 alpha derivate on the development of indomethacin-induced intestinal mucosal damage in rats.
    Garamszegi M; Beró T; Jávor T; Mózsik G
    Acta Physiol Hung; 1984; 64(3-4):349-53. PubMed ID: 6397968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L-dopa is protective against indomethacin-induced small intestinal ulceration in the rat: possible role of an alpha-2-adrenergic mechanism.
    Kiro A; Zahavi I; Marcus H; Dinari G
    Life Sci; 1992; 51(14):1151-6. PubMed ID: 1325590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1.
    Yoda Y; Amagase K; Kato S; Tokioka S; Murano M; Kakimoto K; Nishio H; Umegaki E; Takeuchi K; Higuchi K
    J Physiol Pharmacol; 2010 Jun; 61(3):287-94. PubMed ID: 20610858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of calcium glucarate on beta-glucuronidase activity and glucarate content of certain vegetables and fruits.
    Dwivedi C; Heck WJ; Downie AA; Larroya S; Webb TE
    Biochem Med Metab Biol; 1990 Apr; 43(2):83-92. PubMed ID: 2346674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exacerbation of indomethacin-induced small intestinal injuries in Reg I-knockout mice.
    Imaoka H; Ishihara S; Kazumori H; Kadowaki Y; Aziz MM; Rahman FB; Ose T; Fukuhara H; Takasawa S; Kinoshita Y
    Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G311-9. PubMed ID: 20508157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved determination of D-glucaric acid in urine.
    Jung K; Scholz D; Schreiber G
    Clin Chem; 1981 Mar; 27(3):422-6. PubMed ID: 7471391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter: Inhibitory effect of cholestyramine on the intestinal ulcer formation in rats given an antiphlogistic agent.
    Takemoto K; Tanaka K
    Gastroenterology; 1974 Oct; 67(4):765-6. PubMed ID: 4414269
    [No Abstract]   [Full Text] [Related]  

  • 33. Protective effect of pranlukast, a cysteinyl-leukotriene receptor 1 antagonist, on indomethacin-induced small intestinal damage in rats.
    Nishio H; Hayashi Y; Terashima S; Takeuchi K
    Inflammopharmacology; 2007 Dec; 15(6):266-72. PubMed ID: 18236018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tacrolimus (FK506), an immunosuppressive agent, prevents indomethacin-induced small intestinal ulceration in the rat: inhibition of inducible nitric oxide synthase expression.
    Kato S; Nishio H; Ogura M; Takeuchi K
    J Pharmacol Sci; 2007 Jan; 103(1):40-7. PubMed ID: 17202747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of capsaicin-sensitive mechanism(s) in the antiulcer defence of intestinal mucosa in rats.
    Evangelista S; Maggi CA; Meli A
    Proc Soc Exp Biol Med; 1987 Mar; 184(3):264-6. PubMed ID: 3823103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide inhibitors ameliorate indomethacin-induced enteropathy in rats.
    Parasher G; Frenklakh L; Goodman ; Siddiqui T; Nandi J; Levine RA
    Dig Dis Sci; 2001 Nov; 46(11):2536-41. PubMed ID: 11713966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small intestinal ulcers and intestinal flora in rats given indomethacin.
    Kent TH; Cardelli RM; Stamler FW
    Am J Pathol; 1969 Feb; 54(2):237-49. PubMed ID: 5765565
    [No Abstract]   [Full Text] [Related]  

  • 38. Interference of UDP-glucuronyltransferase and beta-glucuronidase activity in rat liver microsomes at pH 7.5 with p-nitrophenol and p-nitrophenylglucuronide as substrates.
    Gigon PL; Bickel MH
    Enzyme; 1979; 24(4):230-8. PubMed ID: 39749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D-glucaro-1,4-lactone: its excretion in the bile and urine and effect on the biliary secretion of beta-glucuronidase after oral administration in rats.
    Macfadyen A; Ho KJ
    Hepatology; 1989 Apr; 9(4):552-6. PubMed ID: 2925160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel local recycling mechanism that enhances enteric bioavailability of flavonoids and prolongs their residence time in the gut.
    Xia B; Zhou Q; Zheng Z; Ye L; Hu M; Liu Z
    Mol Pharm; 2012 Nov; 9(11):3246-58. PubMed ID: 23033922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.